{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:45:36Z","timestamp":1772829936407,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.yjmcc.2012.05.006","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T00:51:03Z","timestamp":1337647863000},"page":"291-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["T-type Ca2+ signalling downregulates MEK1\/2 phosphorylation and cross-talk with the RAAS transcriptional response in cardiac myocytes"],"prefix":"10.1016","volume":"53","author":[{"given":"Yann","family":"Ruchon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safietou","family":"Sankhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2012.05.006_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1291\/hypres.29.211","article-title":"Combination therapy with aldosterone blockade and renin\u2013angiotensin inhibitors confers organ protection","volume":"29","author":"Sato","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.CIR.103.1.72","article-title":"Aldosterone production is activated in failing ventricle in humans","volume":"103","author":"Mizuno","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","article-title":"Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes","volume":"104","author":"Harada","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0030","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/en.2002-220943","article-title":"Expression and modulation of steroidogenic acute regulatory protein messenger ribonucleic acid in rat cardiocytes and after myocardial infarction","volume":"144","author":"Casal","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0035","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1210\/en.2004-1057","article-title":"Cardiac synthesis of aldosterone: going, going, gone\u2026?","volume":"145","author":"Funder","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0040","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1210\/en.2004-0295","article-title":"Origin of aldosterone in the rat heart","volume":"145","author":"Gomez-Sanchez","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0045","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.HYP.0000102863.23854.0B","article-title":"Aldosterone increases NHE-1 expression and induces NHE-1-dependent hypertrophy in neonatal rat ventricular myocytes","volume":"42","author":"Karmazyn","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cardfail.2004.03.002","article-title":"Aldosterone directly stimulates cardiac myocyte hypertrophy","volume":"10","author":"Okoshi","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappaB activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.RES.0000038488.38975.1A","article-title":"Involvement of extracellular signal-regulated kinases 1\/2 in cardiac hypertrophy and cell death","volume":"91","author":"Bueno","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0065","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1253\/circj.68.376","article-title":"Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction","volume":"68","author":"Matsumoto","year":"2004","journal-title":"Circ J"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.physiol.70.113006.100455","article-title":"Calcium cycling and signaling in cardiac myocytes","volume":"70","author":"Bers","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI27824","article-title":"Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling","volume":"116","author":"Molkentin","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2009.07.026","article-title":"L-type Ca(2+) current in ventricular cardiomyocytes","volume":"48","author":"Benitah","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0008-6363(99)00070-X","article-title":"Ionic basis of ventricular arrhythmias in remodeled rat heart during long-term myocardial infarction","volume":"42","author":"Aimond","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.CIR.0000138973.55605.38","article-title":"Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction","volume":"110","author":"Perrier","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.1988.sp016916","article-title":"Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells","volume":"395","author":"Hagiwara","year":"1988","journal-title":"J Physiol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ceca.2006.04.017","article-title":"T-type calcium channels in differentiation and proliferation","volume":"40","author":"Lory","year":"2006","journal-title":"Cell Calcium"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0105","first-page":"H2540","article-title":"T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion","volume":"279","author":"Leuranguer","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/jmcc.2002.1535","article-title":"Functional and molecular characterization of a T-type Ca(2+) channel during fetal and postnatal rat heart development","volume":"34","author":"Ferron","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/01.RES.0000106134.69300.B7","article-title":"Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels","volume":"93","author":"Ferron","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ceca.2006.04.025","article-title":"Role of T-type Ca2+ channels in the heart","volume":"40","author":"Vassort","year":"2006","journal-title":"Cell Calcium"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yjmcc.2009.08.021","article-title":"Cardiac T-type Ca(2+) channels in the heart","volume":"48","author":"Ono","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0130","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1172\/JCI39724","article-title":"alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice","volume":"119","author":"Nakayama","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0135","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCRESAHA.108.184051","article-title":"The CaV3.2 T-type Ca2+ channel is required for pressure overload-induced cardiac hypertrophy in mice","volume":"104","author":"Chiang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cvr\/cvr082","article-title":"Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice","volume":"91","author":"Le Quang","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/cvr\/cvq379","article-title":"T-type Ca2+ signaling regulates aldosterone-induced CREB activation and cell death through PP2A activation in neonatal cardiomyocytes","volume":"90","author":"Ferron","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11010-008-9919-x","article-title":"Regulation of T-type Cav3.1 channels expression by synthetic glucocorticoid dexamethasone in neonatal cardiac myocytes","volume":"320","author":"Benmohamed","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj3470275","article-title":"Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro","volume":"347","author":"Aoki","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0160","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0165","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/01.CIR.0000160367.99928.87","article-title":"AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program","volume":"111","author":"Jeong","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0170","first-page":"1222","article-title":"CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism","volume":"14","author":"McKay","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0175","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(00)81177-0","article-title":"New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable?","volume":"93","author":"Karin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0180","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1161\/01.CIR.99.11.1485","article-title":"Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells","volume":"99","author":"Christ","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0185","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1046\/j.1471-4159.2001.00666.x","article-title":"Angiotensin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1\/2-dependent mechanism","volume":"79","author":"Cammarota","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0195","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","article-title":"Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells","volume":"109","author":"Mazak","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000180753.63183.95","article-title":"Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells","volume":"97","author":"Min","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0205","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1210\/er.2009-0013","article-title":"Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases","volume":"30","author":"Beck","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0210","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1128\/MCB.17.7.3947","article-title":"Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor","volume":"17","author":"Krstic","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2008.03.036","article-title":"De-phosphorylation of GR at Ser203 in nuclei associates with GR nuclear translocation and GLUT5 gene expression in Caco-2 cells","volume":"475","author":"Takabe","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0220","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI200418975","article-title":"Enhancement of MEK\/ERK signaling promotes glucocorticoid resistance in CD4+ T cells","volume":"113","author":"Tsitoura","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0225","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1006\/jmcc.2000.1265","article-title":"Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart","volume":"32","author":"Luss","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002100000283","article-title":"Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation","volume":"362","author":"Boknik","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0235","doi-asserted-by":"crossref","first-page":"40827","DOI":"10.1074\/jbc.M405770200","article-title":"Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function","volume":"279","author":"Gergs","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0240","doi-asserted-by":"crossref","first-page":"H792","DOI":"10.1152\/ajpheart.00225.2006","article-title":"Acute modulation of PP2a and troponin I phosphorylation in ventricular myocytes: studies with a novel PP2a peptide inhibitor","volume":"292","author":"Deshmukh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0245","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cvr\/cvr163","article-title":"Enhanced activation of p21-activated kinase 1 in heart failure contributes to dephosphorylation of connexin 43","volume":"92","author":"Ai","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0250","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1\u2013ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.yjmcc.2012.05.006_bb0255","first-page":"46201","article-title":"PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart","author":"Sihag","year":"2009","journal-title":"J Mol Cell Cardiol"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282812001836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282812001836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:21:38Z","timestamp":1758313298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282812001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0022282812001836"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2012.05.006","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-type Ca2+ signalling downregulates MEK1\/2 phosphorylation and cross-talk with the RAAS transcriptional response in cardiac myocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2012.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}